Literature DB >> 19879746

Folic acid consumption reduces resistin level and restores blunted acetylcholine-induced aortic relaxation in obese/diabetic mice.

Sai Wang Seto1, Tsz Yan Lam, Penelope Mei Yu Or, Wayne Yuk Wai Lee, Alice Lai Shan Au, Christina Chui Wa Poon, Rachel Wai Sum Li, Shun Wan Chan, John Hok Keung Yeung, George Pak Heng Leung, Simon Ming Yuen Lee, Sai Ming Ngai, Yiu Wa Kwan.   

Abstract

Folic acid supplementation provides beneficial effects on endothelial functions in patients with hyperhomocysteinemia. However, its effects on vascular functions under diabetic conditions are largely unknown. Therefore, the effect(s) of folic acid (5.7 and 71 microg/kg/day for 4 weeks) on aortic relaxation was investigated using obese/diabetic (+db/+db) mice and lean littermate (+db/+m) mice. Acetylcholine-induced relaxation in +db/+db mice was less than that observed in +db/+m mice. The reduced relaxation in +db/+db mice was restored by consumption of 71 microg/kg folic acid. Acetylcholine-induced relaxation (with and without folic acid treatment) was sensitive to N(G)-nitro-L-arginine methyl ester, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one, geldanamycin and triciribine. In addition, acetylcholine-induced relaxation was attenuated by resistin. The plasma level of resistin in +db/+db mice was sevenfold higher than that measured in +db/+m mice, and the elevated plasma level of resistin in +db/+db mice was reduced by 25% after treatment with 71 microg/kg folic acid. Folic acid slightly increased the ratio of reduced glutathione to oxidized glutathione in +db/+db mice. Moreover, folic acid caused a reduction in PTEN (phosphatase and tensin homolog deleted on chromosome 10) expression, an increase in the phosphorylation of endothelial nitric oxide synthase (eNOS(Ser1177)) and Akt(Ser473), and an enhanced interaction of heat shock protein 90 (HSP90) with eNOS in both strains, with greater magnitude observed in +db/+db mice. In conclusion, folic acid consumption improved blunted acetylcholine-induced relaxation in +db/+db mice. The mechanism may be, at least partly, attributed to enhancement of PI3K/HSP90/eNOS/Akt cascade, reduction in plasma resistin level, down-regulation of PTEN and slight modification of oxidative state. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879746     DOI: 10.1016/j.jnutbio.2009.06.015

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  6 in total

1.  Folic Acid Protects Against Glutamate-Induced Excitotoxicity in Hippocampal Slices Through a Mechanism that Implicates Inhibition of GSK-3β and iNOS.

Authors:  Josiane Budni; Simone Molz; Tharine Dal-Cim; Maria Dolores Martín-de-Saavedra; Javier Egea; Manuela G Lopéz; Carla Ines Tasca; Ana Lúcia Severo Rodrigues
Journal:  Mol Neurobiol       Date:  2017-02-10       Impact factor: 5.590

2.  Moving into a new neighborhood: NOS goes nuclear.

Authors:  Mark T Ziolo; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2013-06-22       Impact factor: 5.000

3.  Effect of barley supplementation on the fecal microbiota, caecal biochemistry, and key biomarkers of obesity and inflammation in obese db/db mice.

Authors:  Jose F Garcia-Mazcorro; David A Mills; Kevin Murphy; Giuliana Noratto
Journal:  Eur J Nutr       Date:  2017-08-16       Impact factor: 5.614

Review 4.  Resistin: functional roles and therapeutic considerations for cardiovascular disease.

Authors:  Md S Jamaluddin; Sarah M Weakley; Qizhi Yao; Changyi Chen
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Folic acid modulates eNOS activity via effects on posttranslational modifications and protein-protein interactions.

Authors:  Sarah Y Taylor; Hannah M Dixon; Shobana Yoganayagam; Natalie Price; Derek Lang
Journal:  Eur J Pharmacol       Date:  2013-06-21       Impact factor: 4.432

6.  Resistin and Cardiac Arrest-A Prospective Study.

Authors:  Raluca M Tat; Adela Golea; Rodica Rahaian; Ştefan C Vesa; Daniela Ionescu
Journal:  J Clin Med       Date:  2019-12-25       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.